Protease Inhibition—An Established Strategy to Combat Infectious Diseases

Therapeutic agents with novel mechanisms of action are urgently needed to counter the emergence of drug-resistant infections. Several decades of research into proteases of disease agents have revealed enzymes well suited for target-based drug development. Among them are the three recently validated...

Descripción completa

Detalles Bibliográficos
Autores principales: Sojka, Daniel, Šnebergerová, Pavla, Robbertse, Luïse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197795/
https://www.ncbi.nlm.nih.gov/pubmed/34071206
http://dx.doi.org/10.3390/ijms22115762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197795/
https://www.ncbi.nlm.nih.gov/pubmed/34071206
http://dx.doi.org/10.3390/ijms22115762

Ejemplares similares